Richard D. Pilnik
CIK: 0001760016
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (50.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
DMAC
DiaMedica Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Pilnik Richard D.
Pilnik Richard D. (SEC CIK 0001760016) files insider reports with the SEC as Director of DiaMedica Therapeutics Inc. (DMAC).
Signal8 holds 2 ownership filings by Pilnik Richard D., all Form 4s, filed between Jan 3, 2025 and Apr 8, 2025. Those filings report 2 transactions, from Jan 2, 2025 to Apr 7, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Pilnik Richard D.'s filings is in MINNEAPOLIS, MN.
Recent filings by Pilnik Richard D.
Other insiders filing for DiaMedica Therapeutics Inc. (DMAC)
- Pauls Dietrich John, President & CEO
- Giuffre Randall Michael, Director
- Kuntz Richard, Director
- O'Connor Daniel J., Director
- Lewis Tanya, Director
- Semba Charles Pauling, Director